Auricular tVNS packaged as earbuds — a clever consumer form factor, modest independent evidence.
Best for users who want auricular tVNS in a familiar earbud form factor, paired with music.
Xen is a pair of earbuds that combine auricular tVNS — electrodes targeting the vagus nerve through the ear canal — with music playback, so the stimulation rides on top of audio. Controlled from a phone with adjustable intensity and several modes. Less clinical lineage than Nurosym, but the consumer experience is closer to wearing AirPods than wearing a medical device.
How we tested: Evidence-based assessment — scored from Neuvana product documentation, the broader auricular tVNS literature and independent 2026 reviews. Not hands-on tested by ONDA.
Limited company-sponsored studies on HRV and sleep; no peer-reviewed RCTs of the Xen device specifically. Mechanism inherits from broader auricular tVNS evidence.
Stimulation mechanism
7.0
Auricular tVNS via in-ear electrodes — targets the auricular vagal branch. Stimulation is synchronised with music playback through the same earbuds.
Protocol flexibility
7.5
Multiple modes (focus, calm, sleep) plus music-paired stimulation. Intensity user-adjustable.
Comfort and wearability
7.0
Earbuds — familiar form factor, but in-ear electrode placement is fiddlier than a tragus clip. Cable to the control unit limits mobility.
Biofeedback and data
5.5
App logs sessions; no on-device HRV. Optional Apple Health integration.
Value
6.5
$399 hardware, no subscription required. More expensive than Pulsetto, less validated than Nurosym.
Pros
+Earbud form factor — most familiar consumer shape in the category
+Stimulation paired with music — turns sessions into something you enjoy
+No subscription required for full functionality
+Multiple modes covering focus, calm, sleep
Cons
−Independent clinical evidence on the Xen device itself is thin
−In-ear electrode placement is fiddlier than a tragus clip
−Tethered to a control unit by a cable
−No on-device HRV measurement
Price: $399 one-time; no subscription (as of 2026-05-21)
Where it leads
Xen by Neuvana takes the most consumer-friendly approach to auricular tVNS in this list. It packages the stimulator as in-ear electrodes built into earbuds, with the parameter playing on top of music from a phone — so a session feels closer to wearing AirPods than wearing a medical device. Modes cover focus, calm and sleep, and intensity is user-controlled. No subscription is required for full operation.
Where it falls short
The evidence base is the weak point. The auricular tVNS mechanism inherits credibility from the broader Parasym/Nurosym literature, but Xen-specific peer-reviewed RCTs do not yet exist; what is published is company-sponsored. The earbud form factor also has a practical downside — in-ear electrode placement is more finicky than a tragus clip, and the device tethers to a control unit by cable.
Who it is for
Choose Xen by Neuvana if the earbud form factor and music-paired sessions make daily use realistic for you, and you are comfortable with a thinner device-specific evidence base. If clinical-grade evidence is the priority, Nurosym is the right pick. If you want a wider protocol library at a lower price, Pulsetto delivers more for less.
Background reading
The biology behind what these devices target — and the protocols that compound with the hardware.